Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
about
Antifungal susceptibility testing: current role from the clinical laboratory perspectiveRecent developments in the management of invasive fungal infections in patients with oncohematological diseasesVoriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosisEarlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testingPharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Importance of operational factors in the reproducibility of Aspergillus galactomannan enzyme immune assayCorrelation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in ChildrenThe serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeSuccess rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaTreatment principles for the management of mold infections.Non-cultural methods for the diagnosis of invasive fungal disease.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia).Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis.Progress in the Diagnosis of Invasive Fungal Disease in Children.The current management landscape: aspergillosis.Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.Utility of DNA sequencing for direct identification of invasive fungi from fresh and formalin-fixed specimens.Iterative breakthrough invasive aspergillosis due to TR(34) /L98H azole-resistant Aspergillus fumigatus and Emericella sublata in a single hematopoietic stem cell transplant patient.Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review.Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q26862478-D316C623-F823-443E-AA3C-1F7E65EB6A8CQ28077381-EE62C9AA-9917-4893-805D-B48688E57C1FQ28540254-AC4EDD42-4DC0-4986-B207-B5319B97B77CQ31149815-FF7E5D58-E335-47A7-924D-77E6697F8F47Q33696043-74AFFEBB-2CA3-4327-8D01-4ECE530BDB6DQ34532546-99177C51-D7A7-4A29-8902-EC126513DE96Q35364077-7C236AD8-A3E2-4BAA-A500-AD6374CC504BQ35672970-C403204A-0A17-45B5-A47D-3B5BB7028651Q36630700-6EBBE52F-FA6A-40C4-8517-06690CE68E86Q37151497-593E3E38-9A0B-4679-9C9E-0366599F22ADQ37287794-EC1CA172-116C-4D6E-8143-6FD15381088DQ37473671-AC8D29E1-12D8-4EEF-8379-D61966D04D33Q38265845-EC71E601-FFC9-4AF6-8335-856F6C4C2EBDQ38266817-918D831E-CE94-4572-99E8-4672A5B05F09Q38508539-FC14231F-A85C-4F0A-8D42-114B2F89E7EBQ39022120-F25AD888-1C6A-43A2-943C-EEBC3DC04B49Q39023027-E2168642-2174-42D9-BBDE-57603E991613Q39416559-D0833BAA-7DD2-46A3-8D10-FE26F248FB45Q40438379-C4F8B0B9-0665-4AA5-A731-A7F6690DE2D4Q41649222-AF49529A-FC06-4E3D-A702-C141A5F9238FQ42253269-85EA19EB-013A-49D5-8ED0-1002EEB16C64Q44231702-CEE8C7B9-0099-4245-ADAA-D53BE60D8F36Q46920426-94C870C6-80C4-4971-B33D-B1070A01B9D8Q49604618-DA28FB8C-37E4-40EC-B3BD-F59813A80326Q52720488-12FE029F-0B87-48C8-B66A-CC3AFE3F9B39Q58775551-47956D2E-789D-49DE-9C82-A19D38F679CE
P2860
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@ast
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@en
type
label
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@ast
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@en
prefLabel
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@ast
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@en
P2093
P2860
P356
P1476
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis
@en
P2093
Alieke G Vonk
Bart-Jan Kullberg
Elizabeth M Johnson
Haran T Schlamm
Johan Maertens
Lay Wai Khin
Louis Y A Chai
Mihai G Netea
Peter F Troke
Peter J Donnelly
P2860
P304
P356
10.1128/JCM.06513-11
P407
P577
2012-05-02T00:00:00Z